How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    MRI-based technologies for assessing non-alcoholic fatty liver disease

    Closed for comments This consultation ended on at   Request commenting lead permission

    4 Recommendations for further research

    4.1 Further research is recommended on:

    • the test accuracy of LiverMultiScan and magnetic resonance elastography (MRE) at the thresholds defined by the companies for people:

      • with indeterminate or discordant results from previous fibrosis testing

      • when transient elastography or acoustic radiation force impulse elastography (ARFI) is unsuitable or has not worked

    • the impact of LiverMultiScan and MRE test results on decisions about care, such as the decision to do a liver biopsy.